Article and Video CATEGORIES

We are very excited to launch a new program for GRACE
Patient Perspectives: Clinical Trials Experiences Through Storytelling
**Please Note -- We have extended the deadline for applications to Friday, March 19, 2021. Don't delay!! fill out the application today!
We are inviting all cancer patients with experience in clinical trials (no matter how large or small) to join us in this new program giving voice to the clinical trials experience.
Through storytelling and sharing their experience, patients can educate others who are considering a clinical trial about this part of the cancer journey. All cancer patients currently enrolled in or with past enrollment in a clinical trial are welcomed and encouraged to apply.
Patients selected to participate in this year's program will work closely with GRACE to develop new educational content for patients across a range of platforms that will help them to become established contributors in the area of advocacy. Participants will receive training on digitally distributed content and social media, and their work will be highlighted and shared by GRACE, along with its network of established leaders in the oncology community and board members with an array of interests and connections. Participants will receive a stipend, training in communication and media platforms, and a tech 'package'. Participants will work with GRACE to develop program formats and production and will present a proposal based on their area of experience in a clinical trial program.
For more information, please take a look at and complete our online Program Form and Application, or download the .pdf version available above, which can be emailed as an attachment to dbrock@cancerGRACE.org. If you have questions please contact Denise Brock, Operations Director for GRACE at dbrock@cancerGRACE.org.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Caregiver and welcome to Grace. I'm sorry that you need to be here and hope we can help. Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...
Hi Bob, Welcome to Grace. I'm sorry about your sil. Unfortunately, cancer becomes resistant to TKIs like tagrisso. Sometimes all of the cancer becomes resistant at once and sometimes just parts...
Hi Kimberly, Welcome to Grace. I'm sorry you are here and glad you've found us.
It sounds like a biopsy would be the next step. I can't speak to what...